---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-032559"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2024-07-08T23:59:59+00:00"
generated_at: "2026-05-31T22:53:37.724323+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bionano raises $10M upfront via registered direct offering; adds $20M potential from milestone warrants

## Summary
- 17.5M shares/equivalents sold at $0.571/share for gross proceeds of ~$10M.
- Concurrent private placement includes Series A & B warrants exercisable at $0.571/share, offering up to $20M additional.
- Series A warrants expire 24 months post-stockholder approval or 60 days after MolDX coverage for optical genome mapping.
- Series B warrants expire 5 years post-approval or 6 months after FDA clearance for optical genome mapping system.
- Net proceeds earmarked for working capital, R&D, debt repayment, and capex; closing expected July 8, 2024.

## SEC filing metadata
- accession: 0001140361-24-032559
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2024-07-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036124032559/0001140361-24-032559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124032559/ny20032138x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-032559
- JSON: https://secwatch.observer/filing/0001140361-24-032559.json
- Plain text: https://secwatch.observer/filing/0001140361-24-032559.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.